journal cover

Current opinion neurology: visual pathway biomarkers in Alzheimer's disease

Current Opinion in Neurology

Dec 7, 2019

Gregory P Van Stavern

Abstract

The incidence of Alzheimer's disease is increasing. Premortem diagnosis of Alzheimer's disease is now possible but require invasive and expensive testing such as PET amyloid beta binding and/or spinal fluid amyloid beta levels. There is a great need for minimally invasive and inexpensiv...read more

Mentioned in this Paper

Evaluation
Literature
Neurology Speciality
Positron-Emission Tomography
Research
Study
Biological Markers
Blood
Dementia
Cerebrospinal Fluid
2
1
1
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Current opinion neurology: visual pathway biomarkers in Alzheimer's disease

Current Opinion in Neurology

Dec 7, 2019

Gregory P Van Stavern

PMID: 31809334

DOI: 10.1097/wco.0000000000000788

Abstract

The incidence of Alzheimer's disease is increasing. Premortem diagnosis of Alzheimer's disease is now possible but require invasive and expensive testing such as PET amyloid beta binding and/or spinal fluid amyloid beta levels. There is a great need for minimally invasive and inexpensiv...read more

Mentioned in this Paper

Evaluation
Literature
Neurology Speciality
Positron-Emission Tomography
Research
Study
Biological Markers
Blood
Dementia
Cerebrospinal Fluid
2
1
1

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/current-opinion-neurology-visual-pathway/31809334